185 related articles for article (PubMed ID: 30464402)
1. Saponins enhance exon skipping of 2'-O-methyl phosphorothioate oligonucleotide in vitro and in vivo.
Wang M; Wu B; Shah SN; Lu P; Lu Q
Drug Des Devel Ther; 2018; 12():3705-3715. PubMed ID: 30464402
[TBL] [Abstract][Full Text] [Related]
2. Pluronic-PEI copolymers enhance exon-skipping of 2'-O-methyl phosphorothioate oligonucleotide in cell culture and dystrophic mdx mice.
Wang M; Wu B; Lu P; Tucker JD; Milazi S; Shah SN; Lu QL
Gene Ther; 2014 Jan; 21(1):52-9. PubMed ID: 24131982
[TBL] [Abstract][Full Text] [Related]
3. Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo.
Wang M; Wu B; Tucker JD; Shah SN; Lu P; Lu Q
J Nanobiotechnology; 2020 Feb; 18(1):34. PubMed ID: 32070342
[TBL] [Abstract][Full Text] [Related]
4. Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In Vitro and in mdx Mice.
Wang M; Wu B; Shah SN; Lu P; Lu Q
Mol Ther Nucleic Acids; 2018 Jun; 11():192-202. PubMed ID: 29858054
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2'-O-methyl RNA mixmer antisense oligonucleotides for exon skipping in vitro.
Le BT; Chen S; Abramov M; Herdewijn P; Veedu RN
Chem Commun (Camb); 2016 Nov; 52(92):13467-13470. PubMed ID: 27790668
[TBL] [Abstract][Full Text] [Related]
6. Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.
Jirka SM; Heemskerk H; Tanganyika-de Winter CL; Muilwijk D; Pang KH; de Visser PC; Janson A; Karnaoukh TG; Vermue R; 't Hoen PA; van Deutekom JC; Aguilera B; Aartsma-Rus A
Nucleic Acid Ther; 2014 Feb; 24(1):25-36. PubMed ID: 24320790
[TBL] [Abstract][Full Text] [Related]
7. Tween 85 grafted PEIs enhanced delivery of antisense 2'-O-methyl phosphorothioate oligonucleotides in vitro and in dystrophic mdx mice.
Wang M; Wu B; Tucker JD; Lu P; Bollinger LE; Lu Q
J Mater Chem B; 2015 Jul; 3(26):5330-5340. PubMed ID: 32262609
[TBL] [Abstract][Full Text] [Related]
8. Phosphorothioate modification of chimeric 2´-O-methyl RNA/ethylene-bridged nucleic acid oligonucleotides increases dystrophin exon 45 skipping capability and reduces cytotoxicity.
Malueka RG; Dwianingsih EK; Yagi M; Lee T; Nishida A; Iijima K; Takeshima Y; Matsuo M
Kobe J Med Sci; 2015 Feb; 60(4):E86-94. PubMed ID: 25791417
[TBL] [Abstract][Full Text] [Related]
9. Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice.
Wang M; Wu B; Tucker JD; Bollinger LE; Lu P; Lu Q
Mol Ther Nucleic Acids; 2016 Aug; 5(8):e341. PubMed ID: 27483024
[TBL] [Abstract][Full Text] [Related]
10. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108
[TBL] [Abstract][Full Text] [Related]
11. Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.
van Putten M; Tanganyika-de Winter C; Bosgra S; Aartsma-Rus A
Nucleic Acid Ther; 2019 Apr; 29(2):92-103. PubMed ID: 30672725
[TBL] [Abstract][Full Text] [Related]
12. Polyquaternium-mediated delivery of morpholino oligonucleotides for exon-skipping in vitro and in mdx mice.
Wang M; Wu B; Shah SN; Lu P; Lu Q
Drug Deliv; 2017 Nov; 24(1):952-961. PubMed ID: 28633548
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse Model.
Echevarría L; Aupy P; Relizani K; Bestetti T; Griffith G; Blandel F; Komisarski M; Haeberli A; Svinartchouk F; Garcia L; Goyenvalle A
Nucleic Acid Ther; 2019 Jun; 29(3):148-160. PubMed ID: 31009315
[TBL] [Abstract][Full Text] [Related]
14. Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice.
Wang M; Wu B; Tucker JD; Lu P; Lu Q
Int J Nanomedicine; 2015; 10():5635-46. PubMed ID: 26366082
[TBL] [Abstract][Full Text] [Related]
15. Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.
Heemskerk H; de Winter CL; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
Ann N Y Acad Sci; 2009 Sep; 1175():71-9. PubMed ID: 19796079
[TBL] [Abstract][Full Text] [Related]
16. In vivo restoration of dystrophin expression in mdx mice using intra-muscular and intra-arterial injections of hydrogel microsphere carriers of exon skipping antisense oligonucleotides.
Cohen SA; Bar-Am O; Fuoco C; Saar G; Gargioli C; Seliktar D
Cell Death Dis; 2022 Sep; 13(9):779. PubMed ID: 36085138
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent pharmacokinetic profiles of 2'-O-methyl phosphorothioate antisense oligonucleotidesin mdx mice.
Verhaart IE; Tanganyika-de Winter CL; Karnaoukh TG; Kolfschoten IG; de Kimpe SJ; van Deutekom JC; Aartsma-Rus A
Nucleic Acid Ther; 2013 Jun; 23(3):228-37. PubMed ID: 23634945
[TBL] [Abstract][Full Text] [Related]
18. Terminal antisense oligonucleotide modifications can enhance induced exon skipping.
Gebski BL; Errington SJ; Johnsen RD; Fletcher S; Wilton SD
Neuromuscul Disord; 2005 Oct; 15(9-10):622-9. PubMed ID: 16084084
[TBL] [Abstract][Full Text] [Related]
19. Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy.
Kendall GC; Mokhonova EI; Moran M; Sejbuk NE; Wang DW; Silva O; Wang RT; Martinez L; Lu QL; Damoiseaux R; Spencer MJ; Nelson SF; Miceli MC
Sci Transl Med; 2012 Dec; 4(164):164ra160. PubMed ID: 23241744
[TBL] [Abstract][Full Text] [Related]
20. Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy.
van Deutekom J; Beekman C; Bijl S; Bosgra S; van den Eijnde R; Franken D; Groenendaal B; Harquouli B; Janson A; Koevoets P; Mulder M; Muilwijk D; Peterburgska G; Querido B; Testerink J; Verheul R; de Visser P; Weij R; Aartsma-Rus A; Puoliväli J; Bragge T; O'Neill C; Datson NA
Nucleic Acid Ther; 2023 Jun; 33(3):193-208. PubMed ID: 37036788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
